Breaking News, Promotions & Moves

Advent International, Warburg Pincus Name Franco Negron CEO of BioPharma Solutions

Negron has 30 years of experience in the pharmaceutical industry including president of commercial operations at Thermo Fisher Scientific.

Advent International, a global private equity investor, and Warburg Pincus, a global growth investor, have appointed Franco Negron CEO of BioPharma Solutions (BPS) following its proposed divestiture from Baxter International Inc. The closing of the divestiture is expected to occur in the second half of 2023. In a statement, Advent said that Negron is a highly accomplished leader with nearly 30 years of experience in the pharmaceutical industry. Most recently, he served for three years as t...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters